The biosimilars market is expected to grow at a CAGR of 49% during the forecast period 2022 to 2028. Biosimilars are biological medical products that are very similar to other biological medicines that have already been approved. Biosimilars are approved under the same pharmaceutical quality, safety, and efficacy standards that apply to all biological drugs. The global biosimilar market is driven by factors such as cost-effectiveness and increasing demand for biosimilars due to the spread of chronic diseases. In addition, the pressure to reduce healthcare expenditures, along with the expiration of patents for various blockbuster drugs and increased approval of biosimilar drugs by the FDA, is expected to accelerate market growth.
A full report of Biosimilars Market is available at:https://orionmarketreports.com/biosimilars-market/53530/
Company Profile
The prominent players operating in the biosimilars market include Pfizer (US), Sandoz (Germany), Biocon (India), Biogen (US), Fresenius Kabi AG (Germany), BoehringerIngelheim (Germany), Merck KgaA (Germany), Mylan (US), Eli Lilly (US), Teva Pharmaceutical (Israel).
Market Segmentation
By Types
- Human growth hormone
- Erythropoietin
- Monoclonal antibodies
- Insulin
- Interferon
- Granulocyte-Colony Stimulating Factor
By Applications
- Blood disorders
- Oncology diseases
- Chronic and autoimmune diseases
- Growth hormone deficiencies
Scope of the Report
The research study analyzes the Biosimilars Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Biosimilars Market Report
- What was the Biosimilars Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).
- What will be the CAGR of Biosimilars Market during the forecast period (2022-2028)?
- Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
- Which manufacturer/vendor/players in the Biosimilars Market was the market leader in 2021?
- Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
- Proliferation and maturation of trade in the Biosimilars market.
- The market share of the Biosimilars market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Biosimilars market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the Biosimilars market.
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
